Replies to post #154475 on Avid Bioservices Inc (CDMO)

[Couch]

Mentioning PPHM in the same sentence with the immunotherapy drugs from the other three companies is off-base, IMO. When I saw that, I knew I didn’t have to read further.

Yet the opinion of why PPHM should not be mentioned alongside these BP's is not offered up and no flip side solid DD or even a speculative rebuttal on the company is offered additionally......and further implied, is that to read the article further is not warranted. Sounds like bad scientific research protocol. I forget what the term is for this flawed methodology related to conducting scientific research outcome. I'm sorry to say my research days are long behind me.

I'm obviously new and haven't been around for 14 years let alone 14 weeks.....the PPHM learning curve is also obviously more than steep for newbies such as myself. I did, however, read the article in question and found it a nice place to start regarding company DD if I am not mistaken???

For those of us less in the flow of the history of the uphill battle having been waged by the company to get to Phase III....please share why IYO PPHM should not have been mentioned with Bristol Myers, Merck, and Roche? Phase III alone may say otherwise....but I certainly could be missing something more pertinent to the more trained eye so to speak.

Thanks,
Couch

[biopharm]

Mentioning PPHM in the same sentence with the immunotherapy drugs from the other three companies is off-base, IMO.

Its a good thing that not everyone purchases biotech stocks based on your opinion, because in my opinion---- Peregrine Pharmaceuticals is the #1 biotech value that will be "required" for "cancer immunotherapy" to be considered true cancer immunotherapy, by targeting PS, which ultimately allows a far greater immune response

[lemmy]

Well said, Dew D. And if I may add something:

BMY @ $52.85
MRK @ $49.73
RHHBY @ $69.61

PPHM @ $ 1.45 (29 cents pre-r/s)

[revenue_monster]

yeah right Ray. Like big Pharma never does anything wrong and all drugs they release are great.

[Protector]

You mean like calling Bavituximab a placebo or like saying it would never get a to PIII or like its PII results would never pass the FDA EOPII should have been a signal for us all not to read further or give any credit to those who posted that?


I wonder who stopped reading when the good Doctor S told PPHM to throw the towel, or when a certain AF piled up more nonsense and doom then all the others together to see himself wrong.

I may have criticized MD in the past but everyone that in this stage would not recognize that PPHM can be mentioned with the 3 BP's that have the PD-1, CTLA-4, etc and need Bavi as an upstream agent in their cocktail to win the race from the others should do some extra D&D.

Because in the end we all know that is what it will come too.

[md1225]

You did not have to read further because you came to the same conclusion as everyone else?

Bavituximab is the clear leader in the immunotherapy race?

Bavituximab is void of the toxic side effects CTL-4, PD-1 and PD-L1 are associated with?

All immunotherapy drugs in development should be combined with Bavituximab to ensure patients receive the best possible clinical response and possible complete remission?

The true winner in the "Race For A Cure" will be the "medium pharma" that partners Peregrine?

CELG GILD BIIB ABBV ??? I hear it's not a big pharma. But what do I know?

Thanks for reading the article Dew! Part 2 will be the article of the year on Seeking Alpha!

Please take a moment and finish reading the whole article.

http://seekingalpha.com/article/1852541-the-race-for-a-cure-for-cancer